Scienture Holdings, Inc. · NASDAQ:SCNX
Scienture — TRxADE HEALTH — Investor Presentation (October 2021)
20 slides from Scienture's investor presentation, Oct 25, 2021
Slide 1: Digitalizing the Retail Pharmacy Experience
Digitalizing the Retail: Pharmacy Experience Investor Presentation NASDAQ: MEDS ?
Slide 2: Safe Harbor Statement
Safe Harbor Statement The information set forth herein contains forward-looking statements. Forward-looking statements include all statements that do not relate solely to historical or current facts, including, but not limited to, statements regarding future operations, financial results, cash flows
Slide 3: About TRxADE HEALTH, INC.
About TRxXADE HEALTH, INC. TRxADE HEALTH, INC. TRXADE is a technology-enabled health services platform company focused (NASDAQ: MEDS) on digitalizing the retail pharmacy experience by optimizing drug Share Price! $4.75 procurement, the prescription journey and patient engagement in the U.S. Market C
Slide 4: Divisions of TRxADE HEALTH
Divisions of TRXADE HEALTH Platform Company with Various B2B + B2C Subsidiaries (520) (TRADE MEDCHEKS (Health Passport) BONUM (TeleHealth) CJ COMMUNITY SPECIALTY PHARMACY INTEGRAF HH PHARMA SOL z (Rx Distributor) (Pharmacy) “Innovation Lab” (Technology Bridge) 1) Pie slices not representative of rev
Slide 5: TRxADE Marketplace
TRxADE Marketplace Our B2B Pharmaceutical Supply Chain Platform U.S. Pharmaceutical Industry* * Projected $685B per year industry size by 2023 and growing; Over 65,000 pharmacy facilities «Approximately 9 out of 10 Americans live within 5 miles of a community pharmacy * Excluding several large natio
Slide 6: TRxADE Marketplace: Our Marketplace Solution
TRXADE Marketplace : Our B2B Pharmaceutical Supply Chain Platform Our Marketplace Solution * TRXADE’s exchange platform offers a clear and concise interface that allows registered independent pharmacies to analyze “up-to-the-minute” supply & pricing from multiple pharma suppliers * Economies of scal
Slide 7: Bonum Health
Bonum Health ic BONUM HEALTH Patient Centric Telehealth Services Access to Board-Certified Providers & Health Assessment Tools from Anywhere Individually or through an employer sponsored program, patients can access board-certified medical providers nationwide using the Bonum Health mobile app and w
Slide 8: Healthcare Infrastructure
Healthcare Infrastructure Pharmacy & Wholesale Divisions Broaden Capabilities INTEGRA| PHARMA SOI Integra Pharma Solutions Integra Pharma Solutions is the pharmaceutical supplier of choice for healthcare organizations of all sizes. The Company’s expertise in the distribution of products extends to a
Slide 9: MedCheks Digital Health Passport
MedCheks Digital Health Passport Secure Display of Vaccination & COVID-19 Test Result Status The MedCheks Health Passport, currently in development, will store an individual’s health records safely in one place leveraging state-of-the-art encryption & blockchain technology, allowing the holder to se
Slide 10: Tomorrow's Digital Health Services Opportunity
Tomorrow’s Digital Health Services Opportunity Current Pharmacy Services Landscape Non-Insurance based technology providers * GoodRx * RO * Hims * Phil New Age Digital Pharmacies * Amazon-PillPak * Alto Pharmacy * Capsule * Nimble * HealthWarehouse ®* True Pill Logistic Providers * ScriptDrop * Uber
Slide 11: TRxADE's Opportunity
TRxADE’s Opportunity The Opportunity Digitally unify brick and mortar retail pharmacies to deliver exceptional patient-centric health services We believe the industry needs: A true partner with experience and A third-party technology solution able to resources! ito, icreate! icamplex ibridges addres
Slide 12: TRxADE's Future Vision: A Digital Health Services Ecosystem
TRxADE’s Future Vision: A Digital Health Services Ecosystem* Goal to Create a Trusted Technology Platform Delivering Exceptional Patient Health Outcomes Telemedicine Telepharmacy Digital Health Passport Access to a _ licensed physician Access to a licensed network pharmacist Comprehensive digital va
Slide 13: TRxADE Industry Comparable Companies
TRxADE Industry Comparable Companies! Valuation? Category: Prescription TRxADE $38.8M Secondary Marketplace Distribution (B2B) Amerisource (Good Neighbor Pharmacy) $25B Primary Supplier Pharmacy Comps - Retail Distribution McKesson (Healthmart) $318 Primary Supplier Cardinal (Leader) $15B Primary Su
Slide 14: Selected Financials
Selected Financials * High Margin: Revenue from transaction fees on marketplace platform (Credit Card/PayPal model) does not include the drugs value (over $100M annually), hence “tech like margins” * Built-Out Platform: 12,950+ registered members with continued platform development requiring minimal
Slide 15: Management
15 Management \ Suren Ajjarapu, Chairman of the Board and Chief Executive Officer Mr. Ajjarapu has served as Chairman of the Board, Chief Executive Officer and Secretary since our acquisition of Trxade Group, Inc., a Nevada corporation (“TRxADE Nevada”) (our predecessor company) on January 8, 2014,
Slide 16: Key Takeaways
Key Takeaways NASDAQ:MEDS TRXADE is a technology-enabled health services platform company focused on digitalizing Annual Revenue Growth the retail pharmacy experience by optimizing drug procurement, the prescription journey (USD $ in Thousands) $17,122 and patient engagement in the U.S. A Tech Focus
Slide 17: Investor Relations Contact
Investor Relations Contact Lucas A. Zimmerman Director MZ North America Main: 949-259-4987 MEDS@mzgroup.us www.mzgroup.us Contact Us TRXADE HEALTH, INC. 3840 Land O' Lakes Boulevard Land O'Lakes, FL 34639 (800) 261-0281 www.trxadehealth.com @TRADE www.trxade.com www.rxintegra.com www.bonumhealth.com
Slide 18: Appendix: Consolidated Balance Sheets
‘TRxADE HEALTH, INC. Consolidated Balance Sheets September 30, 2021, and December 31, 2020 Appendix: ned September 30, December 31, eff er z A Consolidated Balance Sheet Current Assets Cash $ 3,571,889 $ 5,919,578, Accounts Receivable, net 1,008,816 805,043 Inventory 94,822 1,257,754 Prepaid Assets
Slide 19: Appendix: Consolidated Statements of Operations
Appendix: Consolidated Statements of Operations TRxADE HEALTH, INC. Consolidated Statements of Operations For the Three and Nine Months Ended September 30, 2021, and 2020 (unaudited) Three months ended Nine months ended 2021 2020 2021 2020 Revenues S$ 2,550,046 $ 6,332,269 $ 7,501,535 $ 15,128,226 C
Slide 20: Appendix: Reconciliation of Net Income to Adj. EBITDA
Appendix: Reconciliation of Net Income to Adj. EBITDA Reconciliation of Net Income (Loss) attributable to TRADE HEALTH, INC., to Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) and Adjusted EBITDA* For the three months ended For the nine months ended September 30, September 3